Omega Healthcare Investors Inc (OHI)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Omega Healthcare Investors Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 16 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 50.60 $ — 91% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 10.9% failed
- More than 10% revenue growth is expected for the coming year 5.6% failed
- Share count grows by less than 3% a year 8.3% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 27.5% failed
- Gross margin at 40% or higher and without meaningful erosion 44.5% failed
- Goodwill from acquisitions does not grow faster than revenue 6.4% passed
- Net debt below twice EBITDA 3.6 x EBITDA failed
- Operating cash flow covers the profits of the last three years 1,016 m passed
- Return on capital at 15% or higher, or up versus two years ago 7.9% passed
- Insiders hold at least 10% or are net buyers 0.2% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Analysts & Price Target
The price target sits 2.0% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 16
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1.98 | 1.98 – 1.98 | 1,079 | -2.7% | 1 |
| 12/31/2027 | 2.04 | 1.99 – 2.14 | 1,162 | 3.3% | 5 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.39 | 83.90 | 279 | 16.70 | 40.60 | 227 | 212 |
| 2025: Q1 | 0.33 | 22.20 | 277 | 13.80 | 39.40 | 183 | 163 |
| 2025: Q2 | 0.45 | 3.50 | 283 | 11.80 | 48.40 | 239 | 227 |
| 2025: Q3 | 0.58 | 43.80 | 312 | 12.90 | 57.70 | 227 | 240 |
| 2025: Q4 | 0.53 | 33.40 | 322 | 15.20 | 51.20 | 231 | 231 |
| 2026: Q1 | 0.48 | 45.50 | 323 | 16.70 | 46.80 | 219 | 210 |
| 2026: Q2 | 1.19 | 164.40 | 328 | 16.20 | 110.50 | 218 | 218 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 901 | 560 | 366 | 1.82 | 626 | 3,859 | 8,949 |
| 2017 | 908 | 315 | 100 | 0.49 | 578 | 3,555 | 8,773 |
| 2018 | 882 | 498 | 282 | 1.34 | 499 | 3,764 | 8,591 |
| 2019 | 929 | 552 | 341 | 1.54 | 554 | 4,135 | 9,796 |
| 2020 | 892 | 452 | 159 | 0.68 | 708 | 3,842 | 9,497 |
| 2021 | 1,063 | 566 | 417 | 1.71 | 722 | 4,108 | 9,638 |
| 2022 | 878 | 392 | 427 | 1.75 | 626 | 3,803 | 9,405 |
| 2023 | 950 | 489 | 242 | 0.97 | 627 | 3,575 | 9,117 |
| 2024 | 1,051 | 660 | 406 | 1.50 | 749 | 4,537 | 9,898 |
| 2025 | 1,198 | 749 | 590 | 1.90 | 879 | 5,181 | 10,049 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Omega Healthcare Investors, Inc. ist ein Real Estate Investment Trust.
| Employees | 69 |
|---|---|
| Headquarters | Hunt Valley, MD |
| Address | 303 International Circle, 21030 Hunt Valley, United States |
| Phone | 410 427 1700 |
| Website | omegahealthcare.com |
| IPO Date | 7. Aug 1992 |
| ISIN | US6819361006 |
Management
| Name | Title | Birth Year |
|---|---|---|
| C. Taylor Pickett CPA | CEO & Director | 1962 |
| Matthew P. Gourmand CPA | President | 1976 |
| Vikas Gupta | Chief Investment Officer | 1982 |
| Gail Dave Makode J.D. | Chief Legal Officer & General Counsel | 1975 |
| Megan M. Krull | Senior Vice President of Data, Intelligence & Government Relations | 1978 |
| Michele Reber | Senior Director of Asset Management | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.